Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Brigham and Women's Hospital
Massachusetts General Hospital
Novartis Pharmaceuticals
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
University of California, Los Angeles
University of Utah
Information provided by (Responsible Party):
Patrick Y. Wen, MD, Dana-Farber/Brigham and Women's Cancer Center
ClinicalTrials.gov Identifier:
NCT01339052
First received: April 18, 2011
Last updated: June 28, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)